Adrian Hill, PhD
Professor of Human Genetics; Director of the Jenner Institute
Co-Director, Oxford Martin Programme on Vaccines; Fellow of Magdalen College
Professor Hill is Director of the Jenner Institute, which focuses on designing and developing vaccines for infectious diseases prevalent in developing countries, such as HIV/AIDS, malaria and tuberculosis. He also heads a group at the Wellcome Trust Centre for Human Genetics which studies genetic susceptibility factors for common bacterial diseases. He is a passionate believer in the power of molecular medicine to design and deliver new health care interventions that will improve the lives of the poorest billion in sub-Saharan Africa and elsewhere. His own vaccine research programme has developed one of the most promising potential vaccines for malaria which is currently in large scale trials in infants in sub-Saharan Africa.
He studied medicine at Trinity College Dublin and then went on to do a PhD in population genetics at the University of Oxford. During his time at the Wellcome Trust Centre for Human Genetics he and his research group studied genetic susceptibility to infections such as malaria, TB, and HIV. He is now developing vaccines which produce cellular (T-cell) immunity using Adenovirus and MVA viral vector vaccines in a prime-boost regime. His group has developed vaccines against malaria which were tested in clinical trials. In 2014 he led a clinical trial of an Ebola vaccine (cAd3-ZEBOV) in response to the West African Ebola virus epidemic. In 2014 Adrian became director of Vaccitech, a spin-out company of the University of Oxford.